Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol via HFNC in COPD and Asthma
NCT03091504Completed
- Sponsor
- Rush University Medical Center
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of salbutamol in chronic obstructive pulmonary disease (COPD) and asthma, sponsored by Rush University Medical Center. Primary endpoint: Forced Expiratory Volume in 1 second change. Started Sep 2017; status: completed.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT03091504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091504.